360 Participants Needed

Educational Strategies for Advanced Kidney Disease

(THRiVE Trial)

Recruiting at 1 trial location
LB
CW
Overseen ByClara Walling
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational strategies rather than medication changes.

What data supports the effectiveness of the treatment Educational Strategies for Advanced Kidney Disease?

Research shows that educational and empowerment programs can improve the quality of life for kidney patients by helping them manage their own care better. Motivational interviewing, a part of this treatment, has been effective in encouraging behavior change and improving patient outcomes in kidney disease management.12345

Is the educational strategy for advanced kidney disease safe for humans?

The educational strategies, including motivational interviewing and tailored education, have been used safely in various health conditions, such as cancer and kidney disease, to improve patient understanding and management of their health.36789

How is the treatment 'Educational Strategies for Advanced Kidney Disease' different from other treatments for kidney disease?

This treatment is unique because it combines educational materials and motivational interviewing to help patients with advanced kidney disease understand their options, including conservative management and advance care planning, which are often overlooked in standard care. It focuses on culturally and linguistically tailored education, making it more accessible and relevant to diverse patient populations.1391011

What is the purpose of this trial?

The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 approaches: 1) "Education", in which participants will be given a video and brochure that provide information about the types of vascular access and what can be expected before and after the vascular access is placed, 2) "Education-Plus", in which participants will be given the video and brochure and will also have sessions by telehealth with a motivational interviewing coach to provide additional support around vascular access placement, and 3) "Usual Care", in which participants will have the usual education provided by their kidney doctor and clinic staff just as if they were not in the study. Participants in all 3 groups will be asked to complete questionnaires by telephone and may be invited to be interviewed about their experience with the study intervention at the end of the study. Study participation will last for about 12 months, with most of the study activities taking place during the first 3 months.

Research Team

DC

Deidra Crews, MD, ScM

Principal Investigator

Johns Hopkins University

LM

Laura M. Dember, MD

Principal Investigator

University of Pennsylvania

JE

Jennifer Flythe, MD

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This trial is for adults over 18 with advanced chronic kidney disease who've discussed hemodialysis with their doctor, visited a nephrologist in the last 18 months, and have specific lab results indicating severe kidney function decline. It's not for those already planning different kidney failure treatments or who can't use the educational materials due to cognitive or visual impairments.

Inclusion Criteria

I have discussed starting hemodialysis with my kidney doctor.
I have seen a kidney specialist for my chronic kidney disease in the last 18 months.
My kidney function is severely reduced or my risk of kidney failure is high.

Exclusion Criteria

I am planning treatment for kidney failure that doesn't involve regular dialysis.
I have an appointment with a surgeon for an evaluation or to create a pathway for dialysis.
You have had a previous surgery to create a blood access point.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Education Phase

Participants receive educational materials and support based on their assigned group: Education, Education-Plus, or Usual Care.

12 weeks
Telehealth sessions and telephone questionnaires

Follow-up

Participants are monitored for outcomes such as vascular access evaluation and decision self-efficacy.

12 months

Treatment Details

Interventions

  • Educational Materials
  • Motivational Interviewing
  • Usual Care
Trial Overview The study compares three ways of teaching about vascular access for hemodialysis: 'Education' uses a video and brochure; 'Education-Plus' adds motivational interviews via telehealth; 'Usual Care' is what patients normally get from doctors. Participants will be randomly assigned to one method and share feedback through questionnaires and possible interviews.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment2 Interventions
Group II: Education-PlusExperimental Treatment4 Interventions
Group III: EducationExperimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Johns Hopkins University

Collaborator

Trials
2,366
Recruited
15,160,000+

University of North Carolina, Chapel Hill

Collaborator

Trials
1,588
Recruited
4,364,000+

Findings from Research

Advance care planning is often overlooked for patients with chronic kidney disease, but it can significantly enhance end-of-life care, highlighting the need for better implementation.
The MY WAY approach, which incorporates motivational interviewing and a healthcare coach, provides a structured method for patients to articulate their values and preferences regarding end-of-life care, with resources available for both patients and healthcare professionals.
Make Your Wishes About You (MY WAY): Using Motivational Interviewing to Foster Advance Care Planning for Patients with Chronic Kidney Disease.Anderson, E., Aldous, A., Lupu, D.[2019]
Empowering and educational initiatives significantly improve the quality of life for renal patients, impacting both psychosocial and functional aspects, which is crucial for overall patient care.
Patients who receive home care and self-care training in hemodialysis show better quality of life, reduced medical service utilization, and higher satisfaction with care, highlighting the benefits of patient education and empowerment.
Is there data to support the concept that educated, empowered patients have better outcomes?Latham, CE.[2019]
A new health literacy intervention, which included a film and motivational interviewing sessions led by dialysis nurses, was positively received by both patients and nurses, indicating its feasibility and acceptability for preparing patients for kidney transplantation.
The intervention fostered meaningful dialogue that enhanced patients' understanding and confidence, although nurses found the motivational interviewing approach challenging, highlighting the need for additional training and support for effective implementation.
Intervening on health literacy by knowledge translation processes in kidney transplantation: A feasibility study.Andersen, MH., Urstad, KH., Larsen, MH., et al.[2022]

References

Make Your Wishes About You (MY WAY): Using Motivational Interviewing to Foster Advance Care Planning for Patients with Chronic Kidney Disease. [2019]
Is there data to support the concept that educated, empowered patients have better outcomes? [2019]
Intervening on health literacy by knowledge translation processes in kidney transplantation: A feasibility study. [2022]
[The Effects of an Empowerment Education Program for Kidney Transplantation Patients]. [2019]
Patient empowerment and motivational interviewing: engaging patients to self-manage their own care. [2022]
Needs and Considerations for Standardization of Kidney Disease Education in Patients with Advanced CKD. [2023]
A Randomized Controlled Trial of a Mobile Clinical Decision Aid to Improve Access to Kidney Transplantation: iChoose Kidney. [2022]
A trial examining an advanced practice nurse intervention to promote medication adherence and symptom management in adult cancer patients prescribed oral anti-cancer agents: study protocol. [2019]
Applying best practices to designing patient education for patients with end-stage renal disease pursuing kidney transplant. [2023]
Integrating Conservative kidney management Options and advance care Planning Education (COPE) into routine CKD care: a protocol for a pilot randomised controlled trial. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity